High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years
Current Oncology · 2024
DOI: 10.3390/curroncol31120549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Kenji Makita und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Chiba, Japan. Hauptthemen laut MEDLINE: Femoral Neoplasms, Femoral Fractures, Palliative Care, Radiotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Bone-modifying agents (BMAs) have been widely used to reduce skeletal-related events, including pathological fractures. Herein, we aimed to clarify the incidence of pathological fractures caused by high-risk femoral bone metastases after palliative radiotherapy (RT) in the BMA era and evaluate the necessity of prophylactic surgical stabilization. We assessed 90 patients with high-risk femoral bone metastases, indicated by Mirels’ scores ≥ 8, without pathological fractures and surgical fixations, who received palliative RT at our institution between January 2009 and December 2018. Pathological fracture incidence was analyzed using the Kaplan–Meier method and was 22.8% and 31.0% at 2 and 6 months, respectively. Pathological fractures were caused by 17 of 65 lesions (26.2%) and 9 of 25 lesions (36.0%) in patients who received BMAs and those who did not, respectively (p = 0.44). Additionally, 17 of 42 lesions (40.5%) and 9 of 48 lesions (18.8%) with axial cortical involvement ≥30 and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Chiba, Japan.
- Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama 791-0280, Ehime, Japan.
ORCID-Profile: Hidekazu Oyoshi, Masaki Nakamura
Förderung
- JSPS KAKENHI
Zitieren
APA
Makita, K., Hojo, H., Oyoshi, H., Fujisawa, T., Nakamura, M., Uchida, G., Koike, Y., Zhou, Y., Tomizawa, K., Fukushi, K., & Zenda, S. (2024). High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years. Current Oncology. https://doi.org/10.3390/curroncol31120549
Vancouver
Makita K, Hojo H, Oyoshi H, Fujisawa T, Nakamura M, Uchida G, et al. High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years. Current Oncology. 2024. doi:10.3390/curroncol31120549
BibTeX
@article{Makita2024,
author = {Makita, Kenji and Hojo, Hidehiro and Oyoshi, Hidekazu and Fujisawa, Takeshi and Nakamura, Masaki and Uchida, Gyo and Koike, Yume and Zhou, Yuzheng and Tomizawa, Kento and Fukushi, Keiko and Zenda, Sadamoto},
title = {High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31120549}
}
EUVIMED